The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67)

ABSTRACT Aims/Introduction Few studies have investigated the renoprotective effect of glucagon‐like peptide‐1 (GLP‐1) receptor in patients with chronic kidney disease (CKD). This study evaluated the effect of dulaglutide 0.75 mg on renal function in Japanese patients with type 2 diabetes and CKD sta...

全面介紹

書目詳細資料

Principais autores:	Ken‐ichi Tsuchida, Shinji Taneda, Isao Yokota, Kazufumi Okada, Yoshio Kurihara, Hiroki Yokoyama, Masahiro Iwamoto, Katsuya Yamazaki, Yasushi Ishigaki, Naoki Manda, Hiroshi Maegawa, Japan Diabetes Clinical Data Management Study Group (JDDM study group)
格式:	Artigo
語言:	Inglês
出版:	Wiley 2022-11-01
叢編:	Journal of Diabetes Investigation
主題:	Chronic kidney disease Dulaglutide Estimated glomerular filtration rate
在線閱讀:	https://doi.org/10.1111/jdi.13877
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!